Skip to content
Lower risk Drug recall · FDA · Published June 19, 2017

Apace KY recalls Amantadine capsules due to label mix-up with cyclobenzaprine

Apace KY LLC recalls 50-capsule amantadine HCl units sold in TN with cyclobenzaprine tablets inside. Label mix-up risks incorrect medication use.

🇺🇸 FDA recall #D-1035-2017DrugApace KY ›
Take action

Contact the company

Recalling firmApace KY LLC12954 Fountain Run Rd · Fountain Run, KY 42133-7914
✎ GovInfoNow plain-language explainer

What happened, in plain English

Apace KY LLC is recalling amantadine HCl capsules that contain cyclobenzaprine tablets instead of the intended medication. This mix-up could lead to taking the wrong drug, which may cause serious health issues. Read more at govinfonow.com/recall/41551-apace-ky-recalls-amantadine-capsules-due-to-label-mix-up.

Source Summary by GovInfoNow · govinfonow.com/recall/41551-apace-ky-recalls-amantadine-capsules-due-to-label-mix-up · Updated October 8, 2026 · FDA enforcement record: FDA #D-1035-2017

Cite this page

“Apace KY recalls Amantadine capsules due to label mix-up with cyclobenzaprine.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41551-apace-ky-recalls-amantadine-capsules-due-to-label-mix-up. Based on FDA recall #D-1035-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1035-2017%22&limit=1).

Why it’s dangerous

The cartons labeled as amantadine capsules contain blister packs of cyclobenzaprine tablets. This mix-up means users might take cyclobenzaprine instead of amantadine, which could cause unintended side effects or health issues.

Who’s affected

Prescription holders of amantadine HCl capsules with cyclobenzaprine tablets inside. People who took these capsules without knowing the mix-up are at risk.

How to tell if you have this one

Check for unit dose cartons labeled 'Amantadine HCl 100 mg Capsules' from Apace KY LLC, manufactured for AvKARE Inc in Pulaski, TN. The NDC code 50268-0069-15 and lot number 16710 (expiring 07/2018) are specific identifiers.

  • Brand
    Apace KY
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    KY
Recall numberProduct, codes & lotsQuantity
D-1035-2017Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15; Lot: 16710, exp 07/20181,483 cartons
D-1036-2017Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15; Lot: 16710, exp 07/2018N/A
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for cartons labeled 'Amantadine HCl 100 mg Capsules' with cyclobenzaprine tablets inside.

Where it went and when

Where it was distributed

Distributed in Kentucky.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: yesKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “KY” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Kentucky.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Jun 19, 201712. FDA classified it Class II: Jul 31, 201723. Published in FDA’s Enforcement Report: Aug 9, 201734. FDA terminated the recall: May 4, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1035-2017 (June 19, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1035-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA